Godshall Douglas Evan's Form 4 filing
Shockwave Medical, Inc. (SWAV) · filed Feb 22, 2023
- Accession no.
- 0001209191-23-012014
- Filed
- Feb 22, 2023
- Trade date
- Feb 21, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 14 non-derivative transactions and 1 derivative transaction. Open-market sales total $5.64M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Godshall Douglas EvanCIK 0001404227 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2023 | Common Stock | FTax withholdingDisposed | −10,053 | $192.88 | −$1,939,022.64 | 144,741 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −400 | $182.68 | −$73,072 | 144,341 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −2,600 | $183.93 | −$478,218 | 141,741 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −1,700 | $184.71 | −$314,007 | 140,041 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −3,518 | $186.02 | −$654,418.36 | 136,523 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −4,087 | $186.86 | −$763,696.82 | 132,436 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −9,042 | $187.79 | −$1,697,997.18 | 123,394 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −2,300 | $188.85 | −$434,355 | 121,094 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −1,100 | $190.00 | −$209,000 | 119,994 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −1,300 | $190.92 | −$248,196 | 118,694 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −1,700 | $192.19 | −$326,723 | 116,994 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −1,853 | $193.10 | −$357,814.3 | 115,141 | Direct | |
| Feb 21, 2023 | Common Stock | SSaleDisposed | −400 | $194.17 | −$77,668 | 114,741 | Direct | |
| Feb 21, 2023 | Common Stock | MOption exerciseAcquired | +30,000 | $3.42 | +$102,600 | 144,741 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2023 | Common Stock | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 364,799 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.